Objective: Adrenomedullin (ADM), secreted by the failing human heart, is a newly discovered potent endogenous vasorelaxing and natriuretic peptide that may play a role in cardiorenal regulation. No data are available on ADM in heart-transplant recipients (Htx) and the aim of this study was to determine the short-and long-term responses of ADM after heart transplantation. Methods: Circulating ADM and its relationship with parameters of cardiovascular hemodynamics, humoral factors and renal function were determined in normal subjects and Htx early (1, 2, 4, 8, 15 and 30 days) and late (32616 months) after transplantation. Additionally, ADM was obtained in matched hypertensive and renal-transplant patients (n59 in each group). Results: Plasma ADM, elevated in heart failure patients, further increased transiently at day 1 after transplantation (from 37.9615.9 to 125.8615.3 pmol / l, P,0.01) and, although decreasing thereafter, remained elevated until the 30th day after transplantation (52.1625.2 pmol / l). Late after transplantation, ADM concentrations were still increased compared to normal values (31.365.3 vs. 19.462.7 pmol / l, P,0.001). ADM positively correlated with endothelin, atrial natriuretic peptide (ANP) and cyclosporine. ADM was also correlated with increased diastolic (r50.68, P,0.04) and systolic (r50.66, P,0.05) blood pressure in late Htx. No relationship was observed between ADM and left ventricular mass index, aldosterone and creatinine. ADM elevation was similar in hypertensive, renal-transplant patients and in Htx. Conclusions: Circulating ADM is increased after heart transplantation, in relation to hypertension, endothelin, cyclosporine and ANP. In view of ADM's biological properties, these results might suggest a compensatory role for ADM against further development of vasoconstriction and fluid retention states after heart transplantation.
Introduction
oppose the co-activation of local and circulating vasoconstrictive and sodium-retaining factors during heart disease. Originally isolated from human pheochromocytoma, Heart transplantation is an important surgical treatment adrenomedullin (ADM) is a newly discovered potent for end-stage congestive heart failure, replacing cardiac endogenous vasorelaxing and natriuretic peptide [1] [2] [3] [4] [5] [6] .
systolic function and normalizing partially the neuroPresent mainly in adrenal medulla, in the cardiovascular humoral activation. Thus, plasma catecholamines, arginine system and in kidneys, ADM is produced by vascular vasopressin and renin-angiotensin-aldosterone values norsmooth muscle cells and by vascular endothelial cells and malize in heart-transplant recipients (Htx). On the other has been recently reported to be secreted by the failing hand, endothelin together with atrial and brain natriuretic human heart [7] . ADM is observed in normal human peptides plasma levels have been generally reported to be plasma [8] and its concentration increases in patients with elevated in Htx [13] [14] [15] [16] [17] . To date, despite its potential hypertension, chronic renal failure [9, 10] , and in congesbeneficial properties, no data has been reported on ADM tive heart failure in proportion to the severity of the disease after heart transplantation. [7, 11, 12] . These recent studies suggest that ADM may This study was therefore designed to determine the circulating ADM levels in heart-transplant recipients, early and late after transplantation, and to investigate ADM's amines during the first week after transplantation. Imclinical significance through correlations between its plasmunosuppressive therapy was induced with equine anma levels and variables of cardiovascular hemodynamics, tilymphocyte globulin (Merieux, France) during the first renal function and hormonal factors implicated in blood five postoperative days in association with a 2 mg / kg / day pressure and body-fluid regulation.
dose of prednisone that was rapidly decreased to 1 mg / kg / day at day 3. Azathioprine was prescribed at an initial dose of 2-3 mg / kg / day, adjusted to keep the white blood cell 2. Methods count .4000. Cyclosporine was introduced on the fourth postoperative day, at an initial dose of 3 mg / kg, titrated to The study was approved by the Institutional Review maintain plasma levels at between 210 to 290 nmol / l. All Board for Human Studies and all subjects gave informed but five of the 25 endomyocardial biopsies performed consent.
during the time of the study were free of rejection. The four 1A and the only 3A grade rejection episodes were 2.1. Study design rapidly resolved, as shown by the following biopsy. To avoid the unstable period just following surgery and, Venous blood samples were obtained in all subjects after except in Fig. 1 showing the plasma ADM time course, the a 30 min rest period in the supine position. Blood was data presented in the tables concerning the early Htx group drawn in normal subjects and in Htx early (1, 2, 4, 8, 15 are the means of all values obtained from the eighth to the and 30 days) and late (32616 months) after transplanta30th day after transplantation. tion. Other body fluid regulatory hormones, such as atrial Nine late Htx, age-and weight-matched, were studied natriuretic peptide (ANP), endothelin and aldosterone, 32616 months after transplantation. All, except one together with plasma creatinine, which is used as an index showing a grade 1A rejection, were free of rejection, as of renal function, and cyclosporine levels were also shown by the nearest endomyocardial biopsy, which were determined simultaneously in Htx. To assess the effect of performed 46641 days apart from the study. Normal subjects, hypertensive and renalNine patients, who needed heart transplantation for endtransplant recipients stage congestive heart failure, were studied from just Nine matched normal subjects, with no history or before to 30 days after transplantation. They usually symptoms of cardiovascular disease, comprised the normal received chronotropic and inotropic supports such as group (controls). The hypertensive (HTA) and renal-transisoproterenol and / or dobutamine, dopamine and catecholplant (Rtx) patient groups were additionally investigated in order to determine a possible effect of hypertension, related or not to cyclosporine therapy, on ADM plasma values. These patients were matched with the late Htx, considering age, weight, systemic blood pressure, creatinine and cyclosporinemia ( Table 1 ). The antihypertensive treatment of the hypertensive patients was composed either of beta-blockers (n55), nitrates (n52), calcium antagonists (n53), angiotensin conversion enzyme inhibitors (n52), central antihypertensive therapy (n52) and / or diuretics (n52). In renal-transplant patients, the hypertensive therapy comprised beta-blockers (n52), nitrates (n52), calcium antagonists (n54) and / or diuretics (n52). ice in EDTA-aprotinin tubes to prevent proteolytic break- ford, MA, USA). The sensitivity of the assay was 0.6 PWT1LVD) 2LVD ]213.6. The left ventricular mass pmol / l. The intra-assay coefficient of variation was 7%.
Radioimmunoassays
index (LVMi) was calculated by dividing the left ventricuOther hormone measurements were made as previously lar mass by the body surface area. reported [14, 15] . Briefly, plasma ANP was determined by radioimmunoassay using kits from Amersham (Buckin-2.6. Statistical analysis ghamshire, UK) after extraction by Sep.Pak C cartridges 18 (Waters). The sensitivity of the assay was 2 pmol / l.
All of the results are expressed as means6SD. DifferPlasma endothelin 1 was assayed using kits from Nichols ences in the time course of plasma ADM after transplantaInstitute (Malinkrodt, UK). The sensitivity of the assay tion were assessed using a two-way ANOVA (effect of was 0.8 pmol / l. Plasma aldosterone was determined by transplantation and effect of days after surgery) with radioimmunoassay using CIS Bio International kits (Gif repeated measures. Other differences between groups were sur Yvette, France). Total blood cyclosporinemia was assessed with one-way ANOVA. When ANOVA was determined by an immunoenzyme assay using the kit from significant, comparisons between individual means were Behring Diagnostics (Cupertino, CA, USA).
performed using the a posteriori Tukey's test. The relationship between two variables was examined by regression analysis. The results were considered to be significant at a 2.4. Hemodynamic parameters level of P,0.05.
Systemic blood pressure was determined with a 16-gauge catheter placed in a radial artery connected to a 3. Results multichannel recorder (Kontron) or using the oscillometric method with an automatic tensiometer (Critikon, Paris, Table 1 presents the clinical and biological characterisFrance). Heart rate was obtained simultaneously (Critikon, tics of the normal subjects, the renal-transplant and hyParis, France).
pertensive patients and of the early and late Htx. Age and body-weight were similar in all groups. Heart rate was 2.5. Echocardiography higher in early Htx than in normal and hypertensive subjects. Systemic blood pressure was similarly increased Echographic data were obtained, in normal subjects and in hypertensive patients, in Rtx and late Htx compared to Htx, after 10 min of rest with the subject in the left controls. The left ventricular mass index of Htx was not decubitus position, using an Advanced Technology Labsignificantly different from that of normal subjects. Plasma oratories Ultramark 9 echodoppler and a 2.25 MHz creatinine was similarly increased in Rtx and Htx, comtransducer. Left ventricular end-diastolic dimension pared to controls. Finally, cyclosporine trough levels (LVD), interventricular septum thickness (IVST) and left decreased over time after heart transplantation and were ventricular posterior wall thickness (PWT) were detersimilar in late Htx and in Rtx. significantly increased both in early and late Htx. Endothelin and aldosterone, increased early after transplantation, decreased significantly thereafter, so that they did not differ significantly from controls late after heart trans-A plasma ADM time course, early after heart transplantation. plantation, is presented on Fig. 1 , together with the range To investigate the clinical significance of increased of normal values. Thus, ADM was elevated in patients ADM in Htx, we determined the correlations between with heart failure just before transplantation (day 0), ADM and the hormonal, biological and hemodynamic compared to controls (37.9615.9 vs. 19.462.7 pmol / l, P,0.05). Heart transplantation induced a transient ADM characteristics of the patients early and late after heart increase at day 1 (from 37.9615.9 to 125.8615.3 pmol / l, transplantation. The results are presented in Table 3 . ADM P,0.01) and, although decreasing progressively thereafter, positively correlated with endothelin (r50.51, P,0.004 ADM remained elevated until the 30th day after transand r50.86, P,0.003, early and late, respectively, after plantation (52.1625.2 pmol / l), compared to the control heart transplantation). A positive correlation was also values.
observed between ADM and ANP early (r50.54, P, Plasma ADM values in the five groups of subjects are 0.008) but it just failed to reach statistical significance late shown in Fig. 2 . ADM is increased in renal-transplant, after transplantation (r50.62, P50.07). ADM and syshypertensive and early and late heart-transplant patients, temic blood pressure were positively correlated late after compared to controls (44.765.3 pmol / l in Rtx, 55.4616. 5 heart transplantation (r50.68, P,0.04 and r50.66, P, pmol / l in HTA, 49.9614.9 pmol / l in early and 31.365.3 0.05 for diastolic and systolic blood pressure, respectively) pmol / l in late Htx). Circulating ADM levels in our normal and with heart rate early after transplantation (r50.59, subjects were also increased, compared to previously P,0.005). Finally, ADM and cyclosporine were correlated reported values [1, 7, 12] . However, the approximately twoboth early and late after transplantation (r50.41, P,0.007 fold rise in the mean plasma ADM levels in hypertension and r50.66, P,0.05, respectively). No relationship was and heart failure patients observed in our study was similar observed between ADM and the left ventricular mass to the change in ADM reported by other groups [10- index, aldosterone or creatinine. A positive correlation 12,18], although the absolute values differed.
between endothelin and cyclosporine (r50.59, P,0.001) The plasma levels of body-fluid and blood pressure was also observed in Htx. No significant correlation was regulatory hormones, determined in controls and in early observed between ADM and blood pressures or creatinine in HTA and Rtx and between ADM and cyclosporine in variations may be related to plasma endothelin variations Rtx.
late after heart transplantation. In this regard, the positive correlations between cyclosporine and ADM, on the one hand, and between cyclosporine and endothelin, on the 4. Discussion other, might suggest that cyclosporine partly increases ADM secretion in Htx through its stimulating action on The present study demonstrates, for the first time, that endothelin secretion [24] . circulating ADM is increased, early and late, after heart Besides endothelin, multiple local and circulating factransplantation and that ADM positively correlates with tors, such as cytokines, ANP and steroids, have been blood pressure, endothelin, cyclosporine and ANP in Htx.
shown to increase ADM production from vascular endoInterestingly, ADM is also similarly elevated in matched thelial and smooth muscle cells [3] [4] [5] . Thus, as in other hypertensive and renal-transplant patients.
cardiac surgery procedures, cardiopulmonary bypass-inThe origin of increased circulating ADM after heart duced cytokine release may explain the transient ADM transplantation is unknown, but it may result from deincrease observed at day 1 after heart transplantation [4] . creased clearance and / or increased production. Few data Indeed, a positive correlation between ADM increment and are available concerning the clearance pathway of ADM, aortic cross-clamp time was observed in coronary-arterybut if the adrenal glands and the heart are not important bypass patients [25, 26] . ANP may also participate in ADM catabolism sites, ADM appears to be degraded in human elevation in Htx since it has been shown that ANP infusion lungs [19, 20] . In patients with chronic renal failure, plasma increases circulating ADM in healthy humans [27] . Alter-ADM levels are positively correlated with serum creatinine natively, as in heart failure patients [11] , the correlation and inversely correlated with the glomerular filtration rate, between ANP and ADM may suggest that ADM may be in proportion to the severity of renal impairment [9, 10] .
stimulated by increased body fluid volume after heart Consequently, decreased ADM renal clearance may partransplantation [10] [11] [12] 28] . Finally, the dose-dependency ticipate in ADM elevation in Htx. However, consistent of the dexamethasone-induced up-regulation of the gene with data reported in heart failure patients [7] , such a encoding for ADM may explain why low maintenance mechanism is unlikely to play a key role after cardiac steroids therapy did not appear to stimulate ADM secretion transplantation in view of the very mild degree of renal in Htx [29, 30] . impairment and the lack of correlation between ADM and Whether or not increased ADM in Htx may serve as a serum creatinine observed in our Htx.
pathophysiological marker or play a biological role reDirect ventricular secretion of ADM has been reported mains to be determined. As recently demonstrated, circuin patients with heart failure [12] and plasma ADM level lating ADM cannot discriminate between mild congestive has been related to cardiac hypertrophy in animals [21] .
heart failure patients and healthy subjects [31] but, in view Accordingly, plasma ADM elevation in patients with of its potent and long-lasting natriuretic and vasodilatory untreated essential hypertension was recently proposed to effects [5] and of its paracrine actions, increased ADM in be partly related to cardiac hypertrophy [22] . Despite the Htx may have a clinical significance. One may thus lack of relationship between ADM and the LVM index, speculate that, as in heart failure patients [11] , ADM may which might be explained by the relatively small increase be involved in the defense mechanisms against further in Htx's cardiac thickness, hypertension is thus likely to volume expansion and against further systemic and / or participate in ADM release after heart transplantation.
local vascular resistance increases. Indeed, ADM has been Indeed, a positive correlation was observed in late Htx shown to increase local blood flow in heart and kidneys between ADM and systemic blood pressure, and ADM [32, 33] and ADM may thus counteract an endothelinwas similarly increased in matched hypertensive patients induced renal vasoconstriction and / or heart vasculopathy and renal-transplant recipients.
in Htx [34] . Consistent with this theory, human ADM has Interestingly, although these data support a role for been shown to inhibit the endothelin production of vascuhypertension per se in ADM release, whether or not related lar smooth muscle cells [35] , suggesting that the correlato cyclosporine therapy, Htx are characterized by their tion between ADM and cyclosporine may correspond to a specific relationship between ADM and blood pressure, protective effect of ADM against cyclosporine-induced endothelin and cyclosporine. Endothelin is a powerful vasoconstriction, which has been shown to be partly stimulus for ADM production by vascular cells [23] and mediated by endothelin production enhancement [24] . the positive correlation observed between ADM and
In conclusion, circulating ADM is increased, early and endothelin after heart transplantation supports the view that late, after heart transplantation. This increase, similar to endothelin might participate in the ADM increase in Htx.
that observed in matched hypertensive patients, whether or Indeed, although a correlation cannot establish a causal not in need of immunosuppressive therapy, supports a role relationship between two parameters, the significant and for hypertension per se in ADM release in Htx. However, important relationship observed between endothelin and the positive correlations observed specifically in Htx ADM suggests that more than 60% of the plasma ADM between ADM and blood pressure, endothelin, cyclospo-
